Form 8-K - Current report:
SEC Accession No. 0001193125-25-046226
Filing Date
2025-03-05
Accepted
2025-03-05 07:09:37
Documents
17
Period of Report
2025-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d927269d8k.htm   iXBRL 8-K 49481
2 EX-2.1 d927269dex21.htm EX-2.1 474598
3 EX-99.1 d927269dex991.htm EX-99.1 34099
7 GRAPHIC g927269dsp110.jpg GRAPHIC 16547
8 GRAPHIC g927269dsp110a.jpg GRAPHIC 7021
  Complete submission text file 0001193125-25-046226.txt   851559

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jazz-20250304.xsd EX-101.SCH 2858
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20250304_lab.xml EX-101.LAB 18688
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20250304_pre.xml EX-101.PRE 11691
20 EXTRACTED XBRL INSTANCE DOCUMENT d927269d8k_htm.xml XML 3814
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 25708807
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)